Results

Total Results: 230 records

Showing results for "prostate cancer screening".
Users also searched for: psa

21. PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
    April 01, 2013 - Cancer of the prostate is the second most common cancer and the second leading cause of cancer deaths … The prostate cancer antigen-3 gene (PCA3) has recently been found to be overexpressed in prostate cancers … of the prostate is the second most common cancer and the second leading cause of cancer deaths in men … Randomized Study of Screening for Prostate Cancer. … of the prostate is the second most common cancer and the second leading cause of cancer deaths in men

22. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - neoplasms OR "prostate cancer" AND Limits: Meta-Analysis OR prostatic neoplasms OR "prostate cancer … neoplasms OR "prostate cancer" AND "age factors"OR age [ti] OR ethnicityOR ethnic groups OR … neoplasms OR "prostate cancer" AND "hospital volume" OR "surgeon volume" OR "clinical competence" … neoplasms OR "prostate cancer" AND caseload* OR case load* OR case volume* NUMBER OF RESULTS … neoplasms OR "prostate cancer" AND prostate-specific antigen OR "tumor characteristics" OR "tumor

23. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - neoplasms OR "prostate cancer" AND Limits: Meta-Analysis OR prostatic neoplasms OR "prostate cancer … neoplasms OR "prostate cancer" AND "age factors"OR age [ti] OR ethnicityOR ethnic groups OR … neoplasms OR "prostate cancer" AND "hospital volume" OR "surgeon volume" OR "clinical competence" … neoplasms OR "prostate cancer" AND caseload* OR case load* OR case volume* NUMBER OF RESULTS … neoplasms OR "prostate cancer" AND prostate-specific antigen OR "tumor characteristics" OR "tumor

24. NIH State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-surveillance/research-protocol
    December 01, 2019 - ) screening. … It was projected that in 2010 over 217,000 men would be diagnosed with cancer of the prostate and about … Watchful waiting and active surveillance are two followup strategies for men with prostate cancer. … In addition to prostate neoplasms/cancer, search terms will include “active surveillance,” “watchful … cancer screening standards, treatment, et cetera.

25. Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/research
    December 01, 2019 - Therapies for Clinically Localized Prostate Cancer: Update of a … Trial (PIVOT) compared radical prostatectomy (RP) and watchful waiting (WW) in localized prostate cancer … While the SPCG-4 study found that RP reduced prostate cancer–specific mortality at 12 and 15 years, the … Six nonrandomized comparison studies reported that all-cause and prostate cancer–specific mortality was … https://effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/research

26. Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-protocol.pdf
    June 05, 2024 - neoplasms"[title] OR "prostatic neoplasms"[title] OR sarcomas[title] OR "stomach neoplasms"[title] … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND … neoplasms"[title] OR "prostatic neoplasms"[title] OR sarcomas[title] OR "stomach neoplasms"[title] … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND

27. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary Comparative Effectiveness Review … Number 230 Therapies for Clinically Localized Prostate Cancer Evidence Summary Main Points … Prostate cancer mortality is infrequent in low-risk disease, and all-cause or prostate cancer mortality … Prostate cancer mortality and metastases were rare in all three groups. … Clinically Localized Prostate Cancer Evidence Report ECRI Institute,.

28. 04-E029-1 Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - screening. … Indeed, more than half of prostate cancers detected by PSA screening are expected to be early-stage, … of the Prostate Strategic Urologic Research Endeavor). … of the Prostate Urologic Research Endeavor (CaPSURE) database, 5 the National Cancer Database (NCDB) … Similarly, black patients with prostate cancer were at higher risk for death due to prostate cancer compared

29. Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - prostate cancer have cancer confined to the prostate gland or clinically localized prostate cancer … 1) Baseline PSA 2) Gleason score 3) Tumor index scores (e.g., Cancer of the Prostate Risk Assessment … EAU-ESTRO-SIOG Guidelines on Prostate Cancer. … Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. … of the Prostate Risk Assessment Score CLPC= clinically localized prostate cancer EAU= European Association

30. Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Research Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-protocol.pdf
    April 17, 2024 - men are affected by prostate cancer disproportionately compared with White men,4 with a prostate cancer … These include reduced access to prostate-specific antigen-based (PSA) screening and high- quality prostate … Prostate cancers vary in rates of progression, with some being very indolent. … in men with low-risk prostate cancer. … Cancer Stat Facts: Prostate Cancer.

31. Brooks_ECCS2012 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/brooks_eccs2012.pdf
    January 01, 2012 - Cancer Screening  Guidelines Durado  Brooks, M.D., M.P.H. … with prostate cancer screening.   … findin prostate  cancer at an earlier stage. • Screening might lower a man’s risk of dying from   … prostate cancer — but this is not entirely  clear. • Screening gives many false-­‐negative  and …  Cancer  Screening  Guidelines for Health Care Professionals issued by  the American Cancer

32. Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
    April 01, 2013 - “A recent evidence review found no reduction in prostate cancer-specific mortality based on tPSA screening … Maybe it is enough to simply state that the use and effectiveness of prostate cancer screening with … This may or may not influence the sensitivity and specificity of prostate cancer screening with PSA. … cancer screening. … cancer screening.

33. Can screening among the general adult male population for elevated PCA3 (also known as DD3) gene expression, to identify those at risk for prostate cancer who may be candidates for prostate biopsy, reduce morbidity and mortality? | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/can-screening-among-the-general-adult-male-population-for-elevated-pca3-also-known-as-dd3-gene-expression-to-identify-those-at-risk-for-prostate-cancer-who-may-be-candidates-for-prostate-biopsy-reduce-morbidity-and-mortality
    November 01, 2017 - elevated PCA3 (also known as DD3) gene expression, to identify those at risk for prostate cancer who … , to identify those at risk for prostate cancer who may be candidates for prostate biopsy, reduce morbidity … cancer screening tests vs. screening by PSA testing, other screening methods, or no screening. … May lead to unnecessary follow-up for men who are asymptomatic or have slowly progressing prostate cancer … Prostate cancer is among the most frequently diagnosed and deadliest cancers among men in the U.S.

34. Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_disposition-comments.pdf
    July 03, 2012 - Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment Source: http … Multigene Panels in Prostate Cancer Risk Assessment. … A summary of the genetics of prostate cancer as well as of its heritability would have been welcome, … part of the introduction has been re- organized, to make information on genetics of prostate cancer … We have added a reference to the Vickers paper in JCO to the summary of prostate cancer screening in

35. Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/hypofractionated-radiation-therapy/protocol
    December 01, 2024 - Black men are affected by prostate cancer disproportionately compared with White men, 4 with a prostate … These include reduced access to prostate-specific antigen-based (PSA) screening and high-quality prostate … 6 , 7 Prostate cancers vary in rates of progression, with some being very indolent. … in men with low-risk prostate cancer.  … Cancer Stat Facts: Prostate Cancer.

36. Blood-based Tests for Multiple Cancer Screening: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/cell-free-dna/protocol
    July 01, 2024 - neoplasms"[title] OR "prostatic neoplasms"[title] OR sarcomas[title] OR "stomach neoplasms"[title] OR … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND … neoplasms"[title] OR "prostatic neoplasms"[title] OR sarcomas[title] OR "stomach neoplasms"[title] OR … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND

37. Treating Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/consumer
    November 01, 2020 - How common is prostate cancer? … Who is at risk for prostate cancer? … The risk of prostate cancer is higher for men with a history of prostate cancer in their family. … What tests check for prostate cancer? … Adenocarcinoma Research Protocol Jul 22, 2024 Blood-based Tests for Multiple Cancer Screening

38. Evidence-based Practice Center Review Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
    May 19, 2011 - Currently, most prostate cancer in men in the United States is found by prostate-specific antigen ( … PSA) screening. … It was projected that in 2010 over 217,000 men would be diagnosed with cancer of the prostate and about … In addition to prostate neoplasms/cancer, search terms will include “active surveillance,” “watchful … patients, prostate cancer screening standards, treatment, et cetera.

39. Hypofractionated Radiation Therapy for Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/hypofractionated-radiation-therapy
    June 01, 2024 - cancer in his lifetime 1 ; prostate cancer is the leading type of cancer among men (age-adjusted incidence … Key statistics for prostate cancer. Accessed December 19, 2023. … https://www.cancer.org/cancer/prostate-cancer/about/key-statistics . … Cancer Stat Facts: Prostate Cancer. … Anal Cancer Research Protocol Jul 22, 2024 Blood-based Tests for Multiple Cancer Screening

40. Layout 1 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
    February 01, 2008 - Men with low-grade prostate cancers had a minimal risk of dying from prostate cancer (7 percent with … Prostate cancers not detected by PSA testing. … Regional differences Medium • Physician availability, prostate cancer screening, incidence, and mortality … Low • The risk of overall or prostate cancer death over 10 years for PSA-detected prostate cancers according … High • Screening with PSA testing detects more prostate cancer and cancers of smaller volume, earlier